IMR Press / EJGO / Volume 41 / Issue 3 / DOI: 10.31083/j.ejgo.2020.03.5195
Open Access Case Report
Safe fertility-preserving management in a young woman with endometrial cancer
Show Less
1 Department of Gynecology, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang, China
2 Department of Gynecology and Obstetrics, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China
Eur. J. Gynaecol. Oncol. 2020, 41(3), 476–479;
Submitted: 14 February 2019 | Accepted: 3 June 2019 | Published: 15 June 2020

Endometrial cancer (EC) is a malignant cancer originating from the uterine endometrium. Although the incidence of endometrial cancer in reproductive age is relatively low, its impact on pregnancy outcome is critical. To date, it is difficult to find a standard method which can be referred to these patients who have a strong desire to preserve fertility. Presented is a report of a 35-year-old women with early-stage Endometrial cancer treated with progestin and levonorgestrel-releasing intrauterine system (LNG-IUS) with a good prognosis.

Endometrial cancer
Levonorgestrel-releasing intrauterine system
Figure 1.
Back to top